Navigation Links
Tinnitus Treatment Summer Sale: AudioNotch Launches Reduced Prices Worldwide
Date:7/17/2013

New York, New York (PRWEB) July 17, 2013

AudioNotch is the world's leading provider of Tinnitus Treatment, offering a customized sound therapy based on scientific evidence. AudioNotch's sound therapy is tailor-made for every user's individual tinnitus frequency, targeting their unique tinnitus problem. Over weeks and months of listening to the therapy, users experience a significant reduction in their tinnitus volume.

For a limited time, AudioNotch is pleased to announce its first ever Summer Sale, taking place from July 17th to July 21st. During this time period, AudioNotch subscriptions will temporarily be available at a significantly reduced price compared to their regular rate.

AudioNotch's software is cloud-based and accessible from any device with internet access. The Tailor-Made Notched Sound Therapy can be downloaded onto any MP3 capable playing device, and users have the added convenience of multiple new features, which include the ability to convert their own songs to sound therapy, as well as a new and improved tinnitus tuner.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10930877.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing
2. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
3. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
4. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
5. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
6. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
7. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
8. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
9. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
10. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
11. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
Breaking Biology Technology:
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
Breaking Biology News(10 mins):